These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7990105)

  • 1. A highly potent, orally active imidazo[4,5-b]pyridine biphenylacylsulfonamide (MK-996; L-159,282): a new AT1-selective angiotensin II receptor antagonist.
    Chakravarty PK; Naylor EM; Chen A; Chang RS; Chen TB; Faust KA; Lotti VJ; Kivlighn SD; Gable RA; Zingaro GJ
    J Med Chem; 1994 Nov; 37(24):4068-72. PubMed ID: 7990105
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
    Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Chang RS; Ondeyka DL; Mantlo NB; Gibson RE; Greenlee WJ; Siegl PK
    Eur J Pharmacol; 1995 Dec; 294(2-3):439-50. PubMed ID: 8750704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.
    Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Schorn TW; Schaffer LW; Naylor EM; Chakravarty PK; Patchett AA; Greenlee WJ
    Am J Hypertens; 1995 Jan; 8(1):58-66. PubMed ID: 7734099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent.
    Kiyama R; Fuji M; Hara M; Fujimoto M; Kawabata T; Nakamura M; Fujishita T
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):450-60. PubMed ID: 7774028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.
    Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
    J Med Chem; 1993 Dec; 36(26):4230-8. PubMed ID: 8277505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.
    Casimiro-Garcia A; Filzen GF; Flynn D; Bigge CF; Chen J; Davis JA; Dudley DA; Edmunds JJ; Esmaeil N; Geyer A; Heemstra RJ; Jalaie M; Ohren JF; Ostroski R; Ellis T; Schaum RP; Stoner C
    J Med Chem; 2011 Jun; 54(12):4219-33. PubMed ID: 21557540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
    Widdop RE; Gardiner SM; Kemp PA; Bennett T
    Br J Pharmacol; 1992 Nov; 107(3):873-80. PubMed ID: 1472980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
    Chang RS; Lotti VJ; Chen TB; O'Malley SS; Bendesky RJ; Kling PJ; Kivlighn SD; Siegl PK; Ondeyka D; Greenlee WJ
    Eur J Pharmacol; 1995 Dec; 294(2-3):429-37. PubMed ID: 8750703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
    Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
    Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M
    Eur J Pharmacol; 1995 Apr; 277(2-3):223-8. PubMed ID: 7493612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists.
    Mantlo NB; Chakravarty PK; Ondeyka DL; Siegl PK; Chang RS; Lotti VJ; Faust KA; Chen TB; Schorn TW; Sweet CS
    J Med Chem; 1991 Sep; 34(9):2919-22. PubMed ID: 1895308
    [No Abstract]   [Full Text] [Related]  

  • 13. Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19.
    Dourish CT; Duggan JA; Banks RJ
    Eur J Pharmacol; 1992 Jan; 211(1):113-6. PubMed ID: 1618259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M; Provost D; Versigny A; Cloarec A
    Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives.
    Carini DJ; Duncia JV; Johnson AL; Chiu AT; Price WA; Wong PC; Timmermans PB
    J Med Chem; 1990 May; 33(5):1330-6. PubMed ID: 2329554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenylpropionic acids as new AT1 selective angiotensin II antagonists.
    Almansa C; Gómez LA; Cavalcanti FL; de Arriba AF; Rodríguez R; Carceller E; García-Rafanell J; Forn J
    J Med Chem; 1996 May; 39(11):2197-206. PubMed ID: 8667363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of [11C]L-159,884: a radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging.
    Hamill TG; Burns HD; Dannals RF; Mathews WB; Musachio JL; Ravert HT; Naylor EM
    Appl Radiat Isot; 1996 Feb; 47(2):211-8. PubMed ID: 8852629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.
    Wong PC; Hart SD; Duncia JV; Timmermans PB
    Eur J Pharmacol; 1991 Sep; 202(3):323-30. PubMed ID: 1748155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: a selective AT1 antagonist.
    Szabo Z; Kao PF; Burns HD; Gibson RE; Hamill TG; Ravert HT; Kim SE; Mathews WB; Musachio JL; Scheffel U; Dannals RF
    J Nucl Med; 1998 Jul; 39(7):1209-13. PubMed ID: 9669396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.
    Mederski WW; Dorsch D; Bokel HH; Beier N; Lues I; Schelling P
    J Med Chem; 1994 May; 37(11):1632-45. PubMed ID: 8201597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.